AmerisourceBergen Corp (ABC)
156.41
+5.48
(+3.63%)
USD |
NYSE |
Mar 24, 16:00
156.44
+0.03
(+0.02%)
Pre-Market: 20:00
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 31.64B |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 3.76% |
| Valuation | |
| PE Ratio | 18.98 |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 0.1358 |
| Price to Book Value | -- |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | 0.485 |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | -31.69 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | 34.92% |
News
Headline
Wire
Time (ET)
Yahoo
03/23 12:57
Yahoo
03/03 05:13
Events
| DATE | TIME | TYPE | PERIOD | REPORTED EPS |
ESTIMATED EPS |
SURPRISE | |
| 05/04/2023* | -- | Results | Q2 2023 | -- | 3.31 | -- | |
| 05/04/2023* | 08:30 EST | Earnings Call | Q2 2023 | -- | -- | -- | |
| 02/01/2023 | -- | Results | Q1 2023 | 2.71 | 2.63 | 2.91% | |
| 02/01/2023 | 08:30 EST | Earnings Call | Q1 2023 | -- | -- | -- | |
| 11/03/2022 | -- | Results | Q4 2022 | 2.60 | 2.57 | 1.03% | |
| 11/03/2022 | 08:30 EST | Earnings Call | Q4 2022 | -- | -- | -- | |
| 08/03/2022 | -- | Results | Q3 2022 | 2.62 | 2.56 | 2.35% | |
| 08/03/2022 | 08:30 EST | Earnings Call | Q3 2022 | -- | -- | -- |
*Estimated Date/Time
Earnings
Profile
Edit
| AmerisourceBergen is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. AmerisourceBergen also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). AmerisourceBergen expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe. |
| URL | https://www.amerisourcebergen.com |
| Investor Relations URL | https://investor.amerisourcebergen.com |
| HQ State/Province | Pennsylvania |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Equity Style | Mid Cap/Value |
| Next Earnings Release | May. 04, 2023 (est.) |
| Last Earnings Release | Feb. 01, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 09, 2023 |
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | 1.865 |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.8724 |
| Yield to Sector | 0.5818 |
| Yield to Industry | 0.7251 |
| Last Dividend Amt. | 0.485 |
| Dividend Frequency | Quarterly |
| Last Ex-Dividend Date | Feb. 09, 2023 |
| Yield (TTM) | 1.21% |
| Forward Yield | 1.24% |
| Payout Ratio | 22.60% |
| Cash Payout Ratio | 19.00% |
| Consistent Payer (5Y) |
|
| Consistent Growth (5Y) |
|
Risk
Total Returns Comparison
Annual Total Returns Versus Peers
As of March 24, 2023.
Fundamentals
| Revenue (TTM) | 241.81B |
| Total Expenses (TTM) | 239.08B |
| Net Income (TTM) | 1.729B |
| Total Assets (Quarterly) | 57.91B |
| Total Liabilities (Quarterly) | 57.83B |
| Shareholders Equity (Quarterly) | -178.13M |
| Cash from Operations (TTM) | 2.550B |
| Cash from Investing (TTM) | -1.736B |
| Cash from Financing (TTM) | -2.610B |
Ratings
Profile
Edit
| AmerisourceBergen is one of three domestic leading pharmaceutical wholesalers. It sources and distributes branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospital networks, and healthcare providers. It and McKesson and Cardinal Health constitute over 90% of the U.S. pharmaceutical wholesale industry. AmerisourceBergen also provides commercialization services for manufacturers of pharmaceuticals and medical devices, global specialty drug logistics (World Courier), and animal health product distribution (MWI Animal Health). AmerisourceBergen expanded its international presence in 2021 by purchasing Alliance Healthcare, one of the leading drug wholesalers in Europe. |
| URL | https://www.amerisourcebergen.com |
| Investor Relations URL | https://investor.amerisourcebergen.com |
| HQ State/Province | Pennsylvania |
| Sector | Healthcare |
| Industry | Medical Distribution |
| Equity Style | Mid Cap/Value |
| Next Earnings Release | May. 04, 2023 (est.) |
| Last Earnings Release | Feb. 01, 2023 |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | Feb. 09, 2023 |
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Top Fund Holders
| Symbol | Dollars Invested | % Weight |
|---|---|---|
| FSHCX | 80.31M USD | 4.43% |
| FXG | 26.98M USD | 4.08% |
| FTCS | 169.01M USD | 2.03% |
| JMVQX | 249.06M USD | 1.69% |
| RWL | 26.09M USD | 1.59% |
| SHISX | 135.25M USD | 1.58% |
| BMEZ | 30.09M USD | 1.52% |
| JVMCX | 295.57M USD | 1.43% |
| JVAQX | 128.56M USD | 1.34% |
| IYK | 21.72M USD | 1.29% |
| ADX | 26.00M USD | 1.24% |
| MCBVX | 160.71M USD | 0.98% |
Other Resources
| Whale Wisdom | 13F Filings |
| Seeking Alpha | Call Transcripts |
| Nasdaq | Insider Trading |
| Nasdaq | Institutional Ownership |
| Nasdaq | Option Chain |
| SEC | SEC Filings |
| ABC Tweets |